RecruitingPHASE1, PHASE2NCT04752774

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

Studying Neuromuscular disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ipsen
Principal Investigator
Ipsen Medical Director
Ipsen
Intervention
IPN10200(biological)
Enrollment
240 target
Eligibility
18-70 years · All sexes
Timeline
20212029

Study locations (30)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04752774 on ClinicalTrials.gov

Other trials for Neuromuscular disease

Additional recruiting or active studies for the same condition.

See all trials for Neuromuscular disease

← Back to all trials